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Background:  Rapid and reliable identification of patients at risk for advanced heart failure (HF) has been a major focus at Intermountain 
Healthcare. To guide the screening and referral of these patients we adapted criteria outlined in the 2013 ACCF/AHA HF Guidelines into 
algorithms that identify potentially eligible patients. Here we discuss the development and early experience of electronic alerting at our 
center.
methods:  An ejection fraction (EF) of ≤ 35% on echocardiograms ordered at Intermountain Healthcare hospitals and clinics triggered the 
algorithms created for LVAD/transplant, implantable cardiac defibrillator (ICD), and cardiac resynchronization therapy (CRT) (Figure 1). The 
identification of possibly eligible patients resulted in an alert. During a 30-day testing phase, alerts were sent to the principal investigator for 
evaluation.
results:  The electronic algorithms generated 87 prompts: 47 for ICD; 9 for CRT; and 31 for LVAD/transplant. The most frequent criteria for 
advanced HF were Cr (71%), BUN elevation (65%), and prior HF-related hospitalization/ED visit (58%). Prompts generated for outpatients 
were more appropriate (84%) compared to inpatients (57%). The main reason for an inappropriate alert was newly-diagnosed HF (37%).
conclusion:  Real-time electronic alerting can be used to identify eligible patients for advanced HF therapies. These alerts can be an 
important tool to improve patient outcomes by promoting early identification and referral for life-saving therapies.
